# A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: UCB Biopharma SRL · Condition: Systemic Lupus Erythematosus

- Company: UCB Biopharma SRL
- Sector: Systemic Lupus Erythematosus
- Primary source: https://clinicaltrials.gov/study/NCT06617325

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.